vs
Side-by-side financial comparison of Allegion (ALLE) and APTARGROUP, INC. (ATR). Click either name above to swap in a different company.
Allegion is the larger business by last-quarter revenue ($1.0B vs $962.7M, roughly 1.1× APTARGROUP, INC.). Allegion runs the higher net margin — 13.4% vs 7.7%, a 5.6% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 9.7%). Over the past eight quarters, Allegion's revenue compounded faster (3.5% CAGR vs 2.6%).
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facili...
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
ALLE vs ATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $962.7M |
| Net Profit | $138.1M | $74.3M |
| Gross Margin | 44.0% | — |
| Operating Margin | 18.9% | 11.0% |
| Net Margin | 13.4% | 7.7% |
| Revenue YoY | 9.7% | 13.5% |
| Net Profit YoY | -6.8% | -26.4% |
| EPS (diluted) | — | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $962.7M | ||
| Q3 25 | $1.1B | $961.1M | ||
| Q2 25 | $1.0B | $966.0M | ||
| Q1 25 | $941.9M | $887.3M | ||
| Q4 24 | $945.6M | $848.1M | ||
| Q3 24 | $967.1M | $909.3M | ||
| Q2 24 | $965.6M | $910.1M |
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $74.3M | ||
| Q3 25 | $188.4M | $127.9M | ||
| Q2 25 | $159.7M | $111.7M | ||
| Q1 25 | $148.2M | $78.8M | ||
| Q4 24 | $144.1M | $100.9M | ||
| Q3 24 | $174.2M | $100.0M | ||
| Q2 24 | $155.4M | $90.5M |
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | — | ||
| Q3 25 | 45.8% | — | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | 44.9% | — | ||
| Q4 24 | 44.1% | — | ||
| Q3 24 | 44.7% | — | ||
| Q2 24 | 44.4% | — |
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | 11.0% | ||
| Q3 25 | 21.8% | 14.2% | ||
| Q2 25 | 21.5% | 14.9% | ||
| Q1 25 | 20.9% | 12.8% | ||
| Q4 24 | 19.5% | 14.2% | ||
| Q3 24 | 22.2% | 15.2% | ||
| Q2 24 | 21.6% | 13.8% |
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | 7.7% | ||
| Q3 25 | 17.6% | 13.3% | ||
| Q2 25 | 15.6% | 11.6% | ||
| Q1 25 | 15.7% | 8.9% | ||
| Q4 24 | 15.2% | 11.9% | ||
| Q3 24 | 18.0% | 11.0% | ||
| Q2 24 | 16.1% | 9.9% |
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $1.13 | ||
| Q3 25 | $2.18 | $1.92 | ||
| Q2 25 | $1.85 | $1.67 | ||
| Q1 25 | $1.71 | $1.17 | ||
| Q4 24 | $1.65 | $1.48 | ||
| Q3 24 | $1.99 | $1.48 | ||
| Q2 24 | $1.77 | $1.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $308.9M | $409.5M |
| Total DebtLower is stronger | $2.0B | $1.1B |
| Stockholders' EquityBook value | $2.1B | $2.7B |
| Total Assets | $5.3B | $5.3B |
| Debt / EquityLower = less leverage | 0.97× | 0.43× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $409.5M | ||
| Q3 25 | $302.7M | $264.8M | ||
| Q2 25 | $656.8M | $169.8M | ||
| Q1 25 | $494.5M | $136.8M | ||
| Q4 24 | $503.8M | $226.2M | ||
| Q3 24 | $878.9M | $327.9M | ||
| Q2 24 | $747.5M | $223.9M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $1.1B | ||
| Q3 25 | $2.1B | $546.0M | ||
| Q2 25 | $2.1B | $535.1M | ||
| Q1 25 | $2.0B | $561.2M | ||
| Q4 24 | $2.0B | $688.1M | ||
| Q3 24 | $2.4B | $822.7M | ||
| Q2 24 | $2.4B | $681.5M |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $2.7B | ||
| Q3 25 | $1.9B | $2.8B | ||
| Q2 25 | $1.8B | $2.7B | ||
| Q1 25 | $1.6B | $2.5B | ||
| Q4 24 | $1.5B | $2.5B | ||
| Q3 24 | $1.6B | $2.5B | ||
| Q2 24 | $1.4B | $2.4B |
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $5.3B | ||
| Q3 25 | $5.2B | $5.1B | ||
| Q2 25 | $4.9B | $4.9B | ||
| Q1 25 | $4.6B | $4.5B | ||
| Q4 24 | $4.5B | $4.4B | ||
| Q3 24 | $5.0B | $4.6B | ||
| Q2 24 | $4.8B | $4.5B |
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 0.43× | ||
| Q3 25 | 1.07× | 0.20× | ||
| Q2 25 | 1.16× | 0.20× | ||
| Q1 25 | 1.24× | 0.22× | ||
| Q4 24 | 1.33× | 0.28× | ||
| Q3 24 | 1.53× | 0.32× | ||
| Q2 24 | 1.69× | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $101.3M | $183.7M |
| Free Cash FlowOCF − Capex | — | $96.9M |
| FCF MarginFCF / Revenue | — | 10.1% |
| Capex IntensityCapex / Revenue | 2.0% | 9.0% |
| Cash ConversionOCF / Net Profit | 0.73× | 2.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $299.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $183.7M | ||
| Q3 25 | $229.5M | $177.6M | ||
| Q2 25 | $209.7M | $126.0M | ||
| Q1 25 | $104.5M | $82.7M | ||
| Q4 24 | $219.0M | $178.2M | ||
| Q3 24 | $231.9M | $229.3M | ||
| Q2 24 | $173.0M | $143.6M |
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $96.9M | ||
| Q3 25 | $209.8M | $114.3M | ||
| Q2 25 | $192.0M | $62.5M | ||
| Q1 25 | $83.4M | $25.9M | ||
| Q4 24 | $194.9M | $112.2M | ||
| Q3 24 | $212.0M | $162.7M | ||
| Q2 24 | $152.1M | $75.4M |
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 10.1% | ||
| Q3 25 | 19.6% | 11.9% | ||
| Q2 25 | 18.8% | 6.5% | ||
| Q1 25 | 8.9% | 2.9% | ||
| Q4 24 | 20.6% | 13.2% | ||
| Q3 24 | 21.9% | 17.9% | ||
| Q2 24 | 15.8% | 8.3% |
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 9.0% | ||
| Q3 25 | 1.8% | 6.6% | ||
| Q2 25 | 1.7% | 6.6% | ||
| Q1 25 | 2.2% | 6.4% | ||
| Q4 24 | 2.5% | 7.8% | ||
| Q3 24 | 2.1% | 7.3% | ||
| Q2 24 | 2.2% | 7.5% |
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | 2.47× | ||
| Q3 25 | 1.22× | 1.39× | ||
| Q2 25 | 1.31× | 1.13× | ||
| Q1 25 | 0.71× | 1.05× | ||
| Q4 24 | 1.52× | 1.77× | ||
| Q3 24 | 1.33× | 2.29× | ||
| Q2 24 | 1.11× | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
